In particular, increase in CD8+CD38+ T cells in SLE patients is associated with reduced cytotoxic capacity, which occurs through suppression of cytotoxic gene expression via the NAD+/sirtuin1/EZH2 pathway [126]. Here, CD8A is linked to systemic lupus erythematosus.